Home / NYT / Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Sailesh kumar 12:05 AM NYT

By GINA KOLATA from NYT Health https://ift.tt/2CQNI7l

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Reviewed by Sailesh kumar on 12:05 AM Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )